| 2026年度 |
SPIRAL |
SPIRAL-RACER20 |
A Protocol of a Real-World Prospective Observational Study of Amivantamab Plus Chemotherapy in Patients
with EGFR Exon 20 Insertion–Positive Non-Small Cell Lung Cancer (SPIRAL-RACER20 study). |
Thorac Cancer |
DOI ↗
|
京都府立医科大学
澤田 凌 |
| 2026年度 |
LOGIK |
TOP-ILD |
Long-term outcomes of upfront combination therapy for PPF: TOP-ILD phase 2 study |
ERJ Open Res |
DOI ↗
|
九州大学
坪内 和哉 |
| 2026年度 |
LOGIK |
LOGIK2201(Braves study) |
Phase II Study of Brigatinib for ALK-positive advanced non-small cell lung cancer with untreated brain metastases (LOGIK2201: BRAVES) |
Int J Lung Cancer |
DOI ↗
|
北里大学
中原 善朗 |
| 2026年度 |
W-JHS |
W-JHS NHL03(POLASTAR) |
Real-World Safety and Efficacy of Pola-R-CHP in Previously Untreated DLBCL: POLASTAR Interim Analysis of 500 Patients |
Cancer Sci |
DOI ↗
|
近畿大学
口分田 貴裕 |
| 2026年度 |
その他 |
肺の生活習慣病コホート研究 |
Clinical Outcomes and Acute Exacerbation Incidence in Combined Pulmonary Fibrosis and Emphysema |
Respirology |
DOI ↗
|
九州大学
坪内 和哉 |
| 2026年度 |
SPIRAL |
SPIRAL-ANA |
A Prospective Observational Study of Anamorelin During Chemoimmunotherapy in Non–Small Cell Lung Cancer with Cachexia (SPIRAL-ANA) |
J Cachexia Sarcopenia Muscle |
DOI ↗
|
京都府立医科大学
森本 健司 |
| 2026年度 |
KYUCOG |
KYUCOG-1901 |
GWAS from a multicenter prospective study of radium-223 in bone-metastatic castration-resistant prostate cancer |
EJNMMI Res |
DOI ↗
|
九州大学
種子島 時祥 |
| 2026年度 |
LOGIK |
TERESA |
One-Year Clinical Remission with Tezepelumab in Severe Asthma: TERESA Single-Arm Prospective Study |
J Allergy Clin Immunol |
DOI ↗
|
東京女子医科大学
神尾 敬子 |
| 2026年度 |
LOGIK |
LOGIK2402 |
First-line taxane- versus pemetrexed-based chemoimmunotherapy for TTF-1–negative nonsquamous non–small cell lung cancer: a propensity score–matched study |
Int J Lung Cancer |
DOI ↗
|
九州大学
大坪 孝平 |
| 2026年度 |
その他 |
肺の生活習慣病コホート研究 |
Long-term survival outcomes associated with inhalation therapy in chronic obstructive pulmonary disease: a 5-year multicenter prospective cohort study |
Eur J Med Res |
DOI ↗
|
九州大学
秋山 元太 |
| 2025年度 |
KYUCOG |
KYUCOG-1901 |
Impact of radium-223 on bone imaging and biochemical markers with and without bone-modifying agents in bone-metastatic castration-resistant prostate cancer: results from the kyucog-1901 study |
Eur J Nucl Med Mol Imaging |
DOI ↗
|
九州大学
塩田 真己 |
| 2025年度 |
その他 |
TEMPER study |
Modified EXTREME regimen versus modified TPEx regimen as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, open-label, randomized, exploratory study (TEMPER study) |
Int J Clin Oncol |
DOI ↗
|
大阪大学
鈴木 基之 |
| 2025年度 |
W-JHS |
W-JHS AA02 |
Phase II study of the triple combination of rabbit ATG,
cyclosporine, and eltrombopag in patients with transfusion-dependent aplastic anemia: West Japan Hematology Study Group (W-JHS) AA02 trial |
Br J Haematol |
DOI ↗
|
獨協医科大学
中村 文美 |
| 2025年度 |
KYUCOG |
KYUCOG-1901 |
Effectiveness and Safety of Radium-223 for Bone-Metastatic Castration-Resistant Prostate Cancer: The KYUCOG-1901 Study |
Cancer Sci |
DOI ↗
|
九州大学
塩田 真己 |
| 2025年度 |
W-JHS |
W-JHS NHL03(POLASTAR) |
Preliminary analysis of a multicenter study of Pola-R-CHP in untreated Japanese patients with DLBCL (POLASTAR) |
Int J Hematol |
DOI ↗
|
関西医科大学
佐竹 敦志 |